196 related articles for article (PubMed ID: 35237605)
1. Role of Integrin αvβ3 in Doxycycline-Induced Anti-Proliferation in Breast Cancer Cells.
Chen YF; Yang YN; Chu HR; Huang TY; Wang SH; Chen HY; Li ZL; Yang YSH; Lin HY; Hercbergs A; Whang-Peng J; Wang K; Davis PJ
Front Cell Dev Biol; 2022; 10():829788. PubMed ID: 35237605
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between integrin αvβ3 and ERα contributes to thyroid hormone-induced proliferation of ovarian cancer cells.
Hsieh MT; Wang LM; Changou CA; Chin YT; Yang YSH; Lai HY; Lee SY; Yang YN; Whang-Peng J; Liu LF; Lin HY; Mousa SA; Davis PJ
Oncotarget; 2017 Apr; 8(15):24237-24249. PubMed ID: 27458161
[TBL] [Abstract][Full Text] [Related]
3. The integrin alpha5beta1 regulates alphavbeta3-mediated extracellular signal-regulated kinase activation.
Ly DP; Corbett SA
J Surg Res; 2005 Feb; 123(2):200-5. PubMed ID: 15680379
[TBL] [Abstract][Full Text] [Related]
4. Thyroid Hormone Induces Oral Cancer Growth via the PD-L1-Dependent Signaling Pathway.
Su KW; Lin HY; Chiu HC; Shen SY; ChangOu CA; Crawford DR; Yang YSH; Shih YJ; Li ZL; Huang HM; Whang-Peng J; Ho Y; Wang K
Cells; 2022 Sep; 11(19):. PubMed ID: 36231010
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between integrin αvβ3 and estrogen receptor-α is involved in thyroid hormone-induced proliferation in human lung carcinoma cells.
Meng R; Tang HY; Westfall J; London D; Cao JH; Mousa SA; Luidens M; Hercbergs A; Davis FB; Davis PJ; Lin HY
PLoS One; 2011; 6(11):e27547. PubMed ID: 22132110
[TBL] [Abstract][Full Text] [Related]
6. A novel protein kinase C alpha-dependent signal to ERK1/2 activated by alphaVbeta3 integrin in osteoclasts and in Chinese hamster ovary (CHO) cells.
Rucci N; DiGiacinto C; Orrù L; Millimaggi D; Baron R; Teti A
J Cell Sci; 2005 Aug; 118(Pt 15):3263-75. PubMed ID: 16014375
[TBL] [Abstract][Full Text] [Related]
7. Integrin αvβ3 in the Mediating Effects of Dihydrotestosterone and Resveratrol on Breast Cancer Cell Proliferation.
Ho Y; Li ZL; Shih YJ; Chen YR; Wang K; Whang-Peng J; Lin HY; Davis PJ
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326308
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin and ERK mediated.
Lin HY; Tang HY; Keating T; Wu YH; Shih A; Hammond D; Sun M; Hercbergs A; Davis FB; Davis PJ
Carcinogenesis; 2008 Jan; 29(1):62-9. PubMed ID: 17984113
[TBL] [Abstract][Full Text] [Related]
9. Thyroid hormone inhibition in L6 myoblasts of IGF-I-mediated glucose uptake and proliferation: new roles for integrin αvβ3.
Incerpi S; Hsieh MT; Lin HY; Cheng GY; De Vito P; Fiore AM; Ahmed RG; Salvia R; Candelotti E; Leone S; Luly P; Pedersen JZ; Davis FB; Davis PJ
Am J Physiol Cell Physiol; 2014 Jul; 307(2):C150-61. PubMed ID: 24808494
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of dihydrotestosterone action on resveratrol-induced anti-proliferation in breast cancer cells with different ERα status.
Chin YT; Yang SH; Chang TC; Changou CA; Lai HY; Fu E; HuangFu WC; Davis PJ; Lin HY; Liu LF
Oncotarget; 2015 Nov; 6(34):35866-79. PubMed ID: 26456774
[TBL] [Abstract][Full Text] [Related]
11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
12. The thyroid hormone-αvβ3 integrin axis in ovarian cancer: regulation of gene transcription and MAPK-dependent proliferation.
Shinderman-Maman E; Cohen K; Weingarten C; Nabriski D; Twito O; Baraf L; Hercbergs A; Davis PJ; Werner H; Ellis M; Ashur-Fabian O
Oncogene; 2016 Apr; 35(15):1977-87. PubMed ID: 26165836
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells.
Das R; Mahabeleshwar GH; Kundu GC
J Biol Chem; 2004 Mar; 279(12):11051-64. PubMed ID: 14704150
[TBL] [Abstract][Full Text] [Related]
14. Actions of l-thyroxine and Nano-diamino-tetrac (Nanotetrac) on PD-L1 in cancer cells.
Lin HY; Chin YT; Nana AW; Shih YJ; Lai HY; Tang HY; Leinung M; Mousa SA; Davis PJ
Steroids; 2016 Oct; 114():59-67. PubMed ID: 27221508
[TBL] [Abstract][Full Text] [Related]
15. Distinct molecular pathways mediate progesterone-induced growth inhibition and focal adhesion.
Lin VC; Woon CT; Aw SE; Guo C
Endocrinology; 2003 Dec; 144(12):5650-7. PubMed ID: 12970168
[TBL] [Abstract][Full Text] [Related]
16. A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway.
Menendez JA; Vellon L; Mehmi I; Teng PK; Griggs DW; Lupu R
Oncogene; 2005 Jan; 24(5):761-79. PubMed ID: 15592521
[TBL] [Abstract][Full Text] [Related]
17. Fibronectin-induced proliferation in thyroid cells is mediated by alphavbeta3 integrin through Ras/Raf-1/MEK/ERK and calcium/CaMKII signals.
Illario M; Cavallo AL; Monaco S; Di Vito E; Mueller F; Marzano LA; Troncone G; Fenzi G; Rossi G; Vitale M
J Clin Endocrinol Metab; 2005 May; 90(5):2865-73. PubMed ID: 15687337
[TBL] [Abstract][Full Text] [Related]
18. Recombinant RGD-disintegrin DisBa-01 blocks integrin α
Danilucci TM; Santos PK; Pachane BC; Pisani GFD; Lino RLB; Casali BC; Altei WF; Selistre-de-Araujo HS
Cell Commun Signal; 2019 Mar; 17(1):27. PubMed ID: 30894182
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells.
Chen YJ; Wei YY; Chen HT; Fong YC; Hsu CJ; Tsai CH; Hsu HC; Liu SH; Tang CH
J Cell Physiol; 2009 Oct; 221(1):98-108. PubMed ID: 19475568
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin increases lung cancer cells migration via activation of the alphavbeta3 integrin/FAK/Akt and NF-kappaB-dependent pathway.
Fong YC; Liu SC; Huang CY; Li TM; Hsu SF; Kao ST; Tsai FJ; Chen WC; Chen CY; Tang CH
Lung Cancer; 2009 Jun; 64(3):263-70. PubMed ID: 18996613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
